Diamino acid derivatives of PpIX as potential photosensitizers for photodynamic therapy of squamous cell carcinoma and prostate cancer: In vitro studies

Journal of Photochemistry and Photobiology B: Biology

Volumn 94, Issue 3, 2009, Pages 214-222

  Kwitniewski, Mateusz ^a,b   Juzeniene, Asta ^b   Ma, Li Wei ^b   Glosnicka, Renata ^c   Graczyk, Alfreda ^d   Moan, Johan ^b,e  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c R and D Immunolab Company Ltd   (Poland)

^d MILITARY UNIVERSITY OF TECHNOLOGY   (Poland)

^e UNIVERSITY OF OSLO   (Norway)

Author keywords

Photodynamic therapy; Photosensitizers; Porphyrins; Prostate cancer; Squamous cell carcinoma

Indexed keywords

ARGININE DERIVATIVE; DIAMINO ACID; PHOTOSENSITIZING AGENT; PORPHYRIN DERIVATIVE; PROTOPORPHYRIN; PROTOPORPHYRIN(ALANINE)2 ARGININE 2; PROTOPORPHYRIN(ARGININE)2; PROTOPORPHYRIN(PHENYLALANINE)2 ARGININE 2; PROTOPORPHYRIN(SERINE)2 ARGININE 2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG EFFICACY; DRUG HALF LIFE; EXPERIMENTAL MODEL; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PHOTODYNAMICS; PHOTOTOXICITY; PRIORITY JOURNAL; PROSTATE CARCINOMA; SQUAMOUS CELL CARCINOMA;

AMINO ACIDS, DIAMINO; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; KINETICS; MALE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PROSTATIC NEOPLASMS; PROTOPORPHYRINS;

EID: 60649094507     PISSN: 10111344     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jphotobiol.2008.11.005     Document Type: Article

References (38)

1. Dougherty T.J., Gomer C.J., Henderson B.W., Jori G., Kessel D., Korbelik M., Moan J., and Peng Q. Photodynamic therapy. J. Natl. Cancer Inst. 90 (1998) 889-905
2. Henderson B.W., and Dougherty T.J. How does photodynamic therapy work?. Photochem. Photobiol. 55 (1992) 145-157
3. Brown S.B., Brown E.A., and Walker I. The present and future role of photodynamic therapy in cancer treatment. Lancet Oncol. 5 (2004) 497-500
4. Friedberg J.S., Mick R., Stevenson J.P., Zhu T., Busch T.M., Shin D., Smith D., Culligan M., Dimofte A., Glatstein E., and Hahn S.M. Phase II trial of pleural photodynamic therapy and surgery for patients with non-small-cell lung cancer with pleural spread. J. Clin. Oncol. 22 (2004) 2192-2201
5. Kaye A.H., Morstyn G., and Brownbill D. Adjuvant high-dose photoradiation therapy in the treatment of cerebral glioma: a phase 1-2 study. J. Neurosurg. 67 (1987) 500-505
6. Skyrme R.J., French J.A., Datta S.N., Allman R., Mason M., and Matthews P.N. A phase-1 study of sequential mitomycin C and 5-aminolaevulinic acid-mediated photodynamic therapy in recurrent superficial bladder carcinoma. Br. J. Urol. 95 (2005) 1206-1210
7. Beck T.J., Kreth F.W., Beyer W., Mehrkens J.H., Obermeier A., Stepp H., Stummer W., and Baumgartner R. Interstitial photodynamic therapy of nonresectable malignant glioma recurrences using 5-aminolevulinic acid induced protoporphyrin IX. Lasers Surg. Med. 39 (2007) 386-393
8. Ortner M.E., Caca K., Berr F., Liebetruth J., Mansmann U., Huster D., Voderholzer W., Schachschal G., Mössner J., and Lochs H. Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study. Gastroenterology 125 (2003) 1355-1363
9. van Duijnhoven F.H., Aalbers R.I., Rovers J.P., Terpstra O.T., and Kuppen P.J. The immunological consequences of photodynamic treatment of cancer, a literature review. Immunobiology 207 (2003) 105-113
10. Allison R.R., Downie G.H., Cuenca R., Hu X.H., Childs C.J.H., and Sibata C.H. Photosensitizers in clinical PDT. Photodiag. Photodyn. Therapy 1 (2004) 27-42
11. Castano A.P., Demidova T.N., and Hamblin M.R. Mechanisms in photodynamic therapy: part one-photosensitizers, photochemistry and cellular localization. Photodiag. Photodyn. Therapy 1 (2004) 279-293
12. Calzavara-Pinton P.G., Venturini M., and Sala R. Photodynamic therapy: update 2006. Part 1: photochemistry and photobiology. J. Eur. Acad. Dermatol. Venereol. 21 (2007) 293-302
13. Vrouenraets M.B., Visser G.W., Loup C., Meunier B., Stigter M., Oppelaar H., Stewart F.A., Snow G.B., and van Dongen G.A. Targeting of a hydrophilic photosensitizer by use of internalizing monoclonal antibodies: A new possibility for use in photodynamic therapy. Int. J. Cancer 88 (2000) 108-114
14. Sternberg E.D., Dolphin D., and Brückner C. Porphyrin-based photosensitizers for use in photodynamic therapy. Tetrahedron 54 (1998) 4151-4202
15. Walczak M.S., Lawniczak-Jablonska K., Sienkiewicz A., Czuba M., Klepka M., and Graczyk A. The local atomic structure of di-alanine amino acid derivative of protoporphyrin IX. J. Phys.: Condens. Matter 19 (2007) 285214
16. 2). I. Determination of quantum yield of fluorescence. Optica Applicata XXXIII (2003) 489-503
17. 2). II. Determination of quantum yield of singlet oxygen FD. Optica Applicata XXXIII (2003) 504-519
18. A. Graczyk, J. Konarski, Complex salts of hematoporphyrin and of its derivatives, their synthesis, and therapeutic agent, United States patent no. 5451599, 1995.
19. Graczyk A., Kwasny M., Ye S., Milosz E., Kowalska A., and Podhajska A. Diaminoacid derivatives of protoporphyrine used as photosensitizers in photodynamic method of tumor diagnosis and treatment. Proc. Soc. Photo. Opt. Instrum. Eng. 5229 (2003) 91-96
20. Kwitniewski M., Kunikowska D., Dera-Tomaszewska B B., Tokarska-Pietrzak E., Dziadziuszko H., Graczyk A., and Glosnicka R. Influence of diamino acid derivatives of protoporphyrin IX on mouse immunological system: preliminary results. J. Photochem. Photobiol. B 81 (2005) 129-135
21. Graczyk A., Kwasny M., and Mierczyk Z. Progress in photodynamic method of tumor diagnosis and treatment. Proc. Soc. Photo. Opt. Instrum. Eng. 4238 (2000) 52-60
22. Zoładek T., Nguyen B.N., Jagiełło I., Graczyk A., Rytka J., cells D.a.d.o.p.p.i.y., and photodamage i. but have no mutagenic effect. Photochem. Photobiol. 66 (1997) 253-259
23. Gomer C.J., Jester J.V., Razum N.J., Szirth B.C., and Murphree A.L. Photodynamic therapy of intraocular tumors: examination of hematoporphyrin derivative distribution and long-term damage in rabbit ocular tissue. Cancer Res. 45 (1985) 3718-3725
24. Malik Z., Amit I., and Rothmann C. Subcellular localization of sulfonated tetraphenyl porphines in colon carcinoma cells by spectrally resolved imaging. Photochem. Photobiol. 65 (1997) 389-396
25. Uzdensky A.B., Ma L.W., Iani V., Hjortland G.O., Steen H.B., and Moan J. Intracellular localisation of hypericin in human glioblastoma and carcinoma cell lines. Lasers Med. Sci. 16 (2001) 276-283
26. Dahle J., Steen H.B., and Moan J. The mode of cell death induced by photodynamic treatment depends on cell density. Photochem. Photobiol. 70 (1999) 363-367
27. Dahle J., Bagdonas S., Kaalhus O., Olsen G., Steen H.B., and Moan J. The bystander effect in photodynamic inactivation of cells. Biochim. Biophys. Acta 1475 (2000) 273-280
28. Kowalska A., Kwiek P., Miłosz E., Gondek G., Romiszewska A., Graczyk A., and Podhajska A.J. Application of electrophoretic methods for detection of protein-porphyrin complexes. Acta Biochim. Pol. 50 (2003) 1155-1163
29. J. Domaniecki, E. Stanowski, A. Graczyk, W. Kozlowski, M. Kalczak, J. Strozyna, Z. Mierczyk, M. Kwasny, M. Najdecki, J. Krupa, The use of photodynamic method in the treatment of malignant melanoma and Merkel cell carcinoma, IPA Conference Nantes. 1998.
30. 2 in diagnostics and treatment of primary and metastatic skin tumors with PDT method. IPA Conference Nantes (1998)
31. Monsù Scolaro L., Castriciano M., Romeo A., Patanè S., Cefalì E., and Allegrini M. Aggregation behavior of protoporphyrin IX in aqueous solutions: clear evidence of vesicle formation. J. Phys. Chem. B 106 (2002) 2453-2459
32. Brown S.B., Shillcock M., and Jones P. Equilibrium and kinetic studies of the aggregation of porphyrins in aqueous solution. Biochem. J. 153 (1976) 279-285
33. Zawacka-Pankau J., Kowalska A., Issaeva N., Burcza A., Kwiek P., Bednarz N., Pramanik A., Banecki B., and Podhajska A.J. Tumor suppressor Fhit protein interacts with protoporphyrin IX in vitro and enhances the response of HeLa cells to photodynamic therapy. J. Photochem. Photobiol. B 86 (2007) 35-42
34. Zawacka-Pankau J., Issaeva N., Hossain S., Pramanik A., Selivanova G., and Podhajska A.J. Protoporphyrin IX interacts with wild-type p53 protein in vitro and induces cell death of human colon cancer cells in a p53-dependent and - independent manner. J. Biol. Chem. 282 (2007) 2466-2472
35. Bugaj A., Kwitniewski M., Iani V., Juzeniene A., Juzenas P., Ma L.W., and Moan J. Photodynamic therapy with di-l-arginine protoporphyrinate on WiDr human colon adenocarcinoma xenografts in athymic nude mice. Photodiag. Photodyn. Therapy 4 (2007) 237-241
36. Savellano M.D., and Hasan T. Targeting cells that overexpress the epidermal growth factor receptor with polyethylene glycolated BPD verteporfin photosensitizer immunoconjugates. Photochem. Photobiol. 77 (2003) 431-439
37. Savellano M.D., Pogue B.W., Hoopes J.P., Vitetta E.S., and Paulsen K.D. Multiepitope HER2 targeting enhances photoimmunotherapy of HER2-overexpressing cancer cells with pyropheophorbide-a immunoconjugates. Cancer Res. 65 (2005) 6371-6379
38. Vrouenraets M.B., Visser G.W., Stigter M., Oppelaar H., Snow G.B., and van Dongen G.A. Targeting of aluminum (III) phthalocyanine tetrasulfonate by use of internalizing monoclonal antibodies: improved efficacy in photodynamic therapy. Cancer Res. 61 (2001) 1970-1975